Considering that rapamycin could effectively ameliorate malfunctions of cardiomyocytes caused by STX12 deficiency in vitro, we aimed to investigate the effectivity of rapamycin on alleviating heart failure in vivo. This evidence concerns the gene STX12 and heart failure.